ALR Technologies announced that it has upgraded its Health-e-Connect Diabetes Management System so that it may facilitate online, insulin dosing consultations for physicians. Through the Health-e-Connect System, prescribing physicians will have the option to get a second opinion online on their recommended insulin dose. The second opinion is from an independent consulting endocrinologist.
The consulting endocrinologist gives the dosing opinion based on a review of actual blood glucose data from the patient’s meter along with other pertinent factors necessary for prescribing. Examples of additional factors include current insulin dosage, height, and weight. ALRT’s Health-e-Connect Diabetes Management System is a practical aid for assisting providers with an online second opinion as patient blood glucose data and other key information can be made available online to the consulting specialist. The result provides an easy method to allow a prescribing clinician to regularly adjust a patient’s insulin dose without an office visit. The Insulin Dose Adjustment Consultation (IDAC) system is in the final testing phase and is expected to be available to the customer in mid-June.
Adjustments in patient insulin doses offers the potential for their insulin dose to be optimized on a regular basis, which may slow the progression of some comorbidities associated with diabetes. Additionally, with the monitoring and care facilitation embedded in the Health-e-Connect System, patients may also find it easier to follow their prescribed insulin regimen. For payers, the widespread adoption of intensive blood glucose management would be a key tool in helping to manage the escalating costs of diabetes care without the cost of additional office visits.
ALRT’s CEO Sidney Chan said: “The clinical practice of diabetes would be improved through a system that ensures patients are more likely to be at their optimal dose of insulin. Intensive blood glucose management has been shown to be effective and some patients who are lucky enough to be treated by high-end endocrinologists have access to its benefits. We want to bring this high level of intensive treatment to primary care physicians and to a much broader population of patients.”
ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website.
For more information on the company visit www.alrt.com
Let us hear your thoughts below:
